HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BAO PHARMA-B

179.100

-3.200-1.76%

Volume:582.40K

Turnover:105.32M

Market Cap:58.38B

PE:-148.38

High:184.300

Open:182.300

Low:171.500

Close:182.300

52wk High:184.300

52wk Low:56.000

Shares:325.98M

HK Float Shares:154.00M

Volume Ratio:0.50

T/O Rate:0.38%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.207

ROE:--

ROA:--

PB:57.81

PE(LYR):-148.38

PS:1102.10

Loading ...

Overview Company News Filings

BAO PHARMA-B Included in Hang Seng Composite Index, Poised for Hong Kong Stock Connect Inclusion and Potential Revaluation

Stock Track | BAO PHARMA-B Soars 10.57% in Intraday Session on Commercialization Prospects and Revenue Forecasts

BAO PHARMA-B Surges Over 10% in Morning Session, Up More Than 440% from IPO Price

BAO PHARMA-B (02659) Full Circulation Explained: How Capital Optimization Empowers Its "Scenario-Driven" Strategy?

Bao Pharmaceuticals Files for Hong Kong-Listed Share Full Circulation

MT Newswires Live

BAO PHARMA-B (02659) Proposes H-Share Full Circulation Plan

Extreme Divergence in HK Biotech IPOs: Bao Pharma Soars 180% While B&K Corp and HanxBio Halve

HK Stock Movement | BAO PHARMA-B (02589) Rises Nearly 5% Against Market Trend, SJ02 Approved for Market Launch and KJ017 NDA Submitted

Stock Track | BAO PHARMA-B Soars 5.08% Intraday on Strong "Three Pillars" Strategy

BAO PHARMA-B (02659): A Sustainable Growth Model Driven by Its "Three Pillars" Strategy

BAO PHARMA-B (02659) Donates HK$1 Million to Support Tai Po Fire Relief and Reconstruction Efforts in Hong Kong

Bao Pharmaceuticals Soars 129% in Hong Kong Trading Debut

MT Newswires Live

Stock Track | BAO PHARMA-B Soars 120.81% in Intraday Trading as Stock Debuts at HK$60.5 vs. Offer Price of HK$26.38

Shares of Shanghai Bao Pharmaceuticals Set to Open at HK$60.5 Each in Hong Kong Debut VS Offer Price HK$26.38 Apiece

THOMSON REUTERS

Bao Pharma Nets HK$921.5 Million from Hong Kong IPO Ahead of Trading Debut

MT Newswires Live

BRIEF-Shanghai Bao Pharmaceuticals Announces Final Offer Price HK$26.38 Per H Share Under Offering

Frenzy! Dark Pool Trading Soars Over 113%!

HK Movers | Bao Pharma Jumps 105% in Grey Market

Tiger Newspress

IPO Update | BAO PHARMA-B (02659) Closes Subscription with HK$269.21B Margin Financing, Oversubscribed 2,690.8 Times

Beyond ADC and PD-1 Competition: How Bao Pharma-B Charts a "Second Growth Curve" in Biopharma

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02659/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02659","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02659\",,,,,undefined,":{"symbol":"02659","market":"HK","secType":"STK","nameCN":"BAO PHARMA-B","latestPrice":179.1,"timestamp":1771834081466,"preClose":182.3,"halted":0,"volume":582400,"delay":0,"changeRate":-0.01755348326933635,"floatShares":154000000,"shares":325981465,"eps":-1.207,"marketStatus":"Not Yet Opened","change":-3.2,"latestTime":"02-23 16:08:01","open":182.3,"high":184.3,"low":171.5,"amount":105318871,"amplitude":0.070214,"askPrice":179.1,"askSize":600,"bidPrice":179,"bidSize":1100,"shortable":0,"etf":0,"ttmEps":-1.279,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771896600000},"marketStatusCode":0,"adr":0,"listingDate":1765296000000,"exchange":"SEHK","adjPreClose":182.3,"openAndCloseTimeList":[[1771810200000,1771819200000],[1771822800000,1771833600000]],"volumeRatio":0.503707,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02659\",,,,,undefined,":{"symbol":"02659","floatShares":154000000,"roa":"--","roe":"--","lyrEps":-1.207,"volumeRatio":0.503707,"shares":325981465,"dividePrice":0,"high":184.3,"amplitude":0.070214,"preClose":182.3,"low":171.5,"week52Low":56,"pbRate":"57.81","psRate":"1102.10","week52High":184.3,"institutionHeld":0,"latestPrice":179.1,"committee":0.294118,"eps":-1.207,"divideRate":0,"volume":582400,"delay":0,"ttmEps":-1.279,"open":182.3,"prevYearClose":77.55,"prevWeekClose":182.3,"prevMonthClose":104,"prevQuarterClose":77.55,"fiveDayClose":145,"twentyDayClose":95.9,"sixtyDayClose":26.38},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02659\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02659\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02659\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1769356800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02659\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02659","date":"2026-02-20","current":-140.031274,"percent":0,"low":-138.174242,"twenty":-79.686668,"median":-71.167377,"eighty":-56.115318,"high":-20.527356,"avg":-72.346964,"sd":22.355353,"marketCap":59426421069},"quantilePoints":[{"date":"2025-12-12","current":-53.146224,"twenty":-53.348389,"median":-51.086695,"eighty":-37.627242,"marketCap":22280833132},{"date":"2025-12-19","current":-56.628418,"twenty":-56.115318,"median":-53.146224,"eighty":-50.330094,"marketCap":23796646945},{"date":"2025-12-24","current":-60.667186,"twenty":-57.368285,"median":-54.841733,"eighty":-51.357726,"marketCap":25573245929},{"date":"2026-01-02","current":-53.689307,"twenty":-58.867149,"median":-56.13619,"eighty":-51.993778,"marketCap":22720908110},{"date":"2026-01-09","current":-60.663453,"twenty":-59.744205,"median":-56.240552,"eighty":-53.146224,"marketCap":25736236661},{"date":"2026-01-16","current":-77.814349,"twenty":-61.547088,"median":-57.565784,"eighty":-53.651638,"marketCap":33119716844},{"date":"2026-01-23","current":-76.125836,"twenty":-72.759479,"median":-58.867149,"eighty":-53.689307,"marketCap":32369959474},{"date":"2026-01-30","current":-79.366151,"twenty":-76.125836,"median":-60.665319,"eighty":-55.0155,"marketCap":33902072360},{"date":"2026-02-06","current":-84.493791,"twenty":-76.125836,"median":-61.547088,"eighty":-55.626475,"marketCap":36183942615},{"date":"2026-02-13","current":-126.016863,"twenty":-78.017279,"median":-67.830536,"eighty":-56.031828,"marketCap":54275913922},{"date":"2026-02-20","current":-138.174242,"twenty":-79.686668,"median":-71.167377,"eighty":-56.115318,"marketCap":59426421069}],"updateTime":1771864916544},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02659\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1189519382","title":"BAO PHARMA-B Included in Hang Seng Composite Index, Poised for Hong Kong Stock Connect Inclusion and Potential Revaluation","url":"https://stock-news.laohu8.com/highlight/detail?id=1189519382","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189519382?lang=en_us&edition=fundamental","pubTime":"2026-02-13 22:10","pubTimestamp":1770991825,"startTime":"0","endTime":"0","summary":"On February 13, Hang Seng Indexes Company announced the results of its quarterly review of the Hang Seng Index Series, with BAO PHARMA-B (02659) being added to the Hang Seng Composite Index. The...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK4585","BK1161","BK4588","VT","HSCI","02659"],"gpt_icon":0},{"id":"1133784238","title":"Stock Track | BAO PHARMA-B Soars 10.57% in Intraday Session on Commercialization Prospects and Revenue Forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=1133784238","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133784238?lang=en_us&edition=fundamental","pubTime":"2026-02-10 12:48","pubTimestamp":1770698939,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B's stock soared 10.57% during the intraday session, reflecting strong investor interest in the biopharmaceutical company.The surge appears driven by positive developments in BAO PHARMA's...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02659"],"gpt_icon":0},{"id":"1190022401","title":"BAO PHARMA-B Surges Over 10% in Morning Session, Up More Than 440% from IPO Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1190022401","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190022401?lang=en_us&edition=fundamental","pubTime":"2026-02-10 11:40","pubTimestamp":1770694828,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) rose more than 10% during the trading session, reaching a high of HK$143, which represents an increase of over 440% from its initial public offering price of HK$26.38. At the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"gpt_icon":0},{"id":"1135953312","title":"BAO PHARMA-B (02659) Full Circulation Explained: How Capital Optimization Empowers Its \"Scenario-Driven\" Strategy?","url":"https://stock-news.laohu8.com/highlight/detail?id=1135953312","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135953312?lang=en_us&edition=fundamental","pubTime":"2026-01-06 09:38","pubTimestamp":1767663537,"startTime":"0","endTime":"0","summary":"In December of last year, following a profound structural reshuffle, Hong Kong's biopharmaceutical sector entered a new window for valuation recovery. As a newly listed 18A company focused on a...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"gpt_icon":0},{"id":"2595799584","title":"Bao Pharmaceuticals Files for Hong Kong-Listed Share Full Circulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2595799584","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595799584?lang=en_us&edition=fundamental","pubTime":"2025-12-30 18:52","pubTimestamp":1767091955,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals  submitted filing materials related to the proposed implementation of its Hong Kong-listed share full circulation with the China Securities Regulatory Commission, according to a Tuesday Hong Kong bourse filing.The biotechnology company is looking to convert over 63.1 million unlisted shares into Hong Kong-listed shares.The shares represent around 19.36% of the firm's issued share capital.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02659"],"gpt_icon":0},{"id":"1182770095","title":"BAO PHARMA-B (02659) Proposes H-Share Full Circulation Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1182770095","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182770095?lang=en_us&edition=fundamental","pubTime":"2025-12-30 17:10","pubTimestamp":1767085831,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) announced that on December 30, 2025, the company submitted filing materials to the China Securities Regulatory Commission for its proposed H-share full circulation plan. The...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"gpt_icon":0},{"id":"1115768100","title":"Extreme Divergence in HK Biotech IPOs: Bao Pharma Soars 180% While B&K Corp and HanxBio Halve","url":"https://stock-news.laohu8.com/highlight/detail?id=1115768100","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115768100?lang=en_us&edition=fundamental","pubTime":"2025-12-24 13:00","pubTimestamp":1766552455,"startTime":"0","endTime":"0","summary":"December 2025 witnessed a dramatic \"tale of two cities\" in Hong Kong's biotech IPO market. On December 10, BAO PHARMA-B (02659) debuted with a 127% surge, peaking at 170% intraday before closing...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1173","02589","159837","02659","03378","BK1587","02396","BK1233","BK1616","BK1535"],"gpt_icon":1},{"id":"1102987607","title":"HK Stock Movement | BAO PHARMA-B (02589) Rises Nearly 5% Against Market Trend, SJ02 Approved for Market Launch and KJ017 NDA Submitted","url":"https://stock-news.laohu8.com/highlight/detail?id=1102987607","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102987607?lang=en_us&edition=fundamental","pubTime":"2025-12-16 11:04","pubTimestamp":1765854287,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02589) gained nearly 5% against the broader market trend, rising 3.79% to HKD 68.45 by the time of writing, with a trading volume of HKD 18.38 million. Recently, BAO PHARMA-B officially...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"13b25d888f050196aeac806a84273b4d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02589","BK1587","BK1616","BK1233","02659"],"gpt_icon":1},{"id":"1139004500","title":"Stock Track | BAO PHARMA-B Soars 5.08% Intraday on Strong \"Three Pillars\" Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=1139004500","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139004500?lang=en_us&edition=fundamental","pubTime":"2025-12-11 09:38","pubTimestamp":1765417124,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) saw its stock price surge by 5.08% during the intraday session on Thursday, reflecting strong investor confidence in the company's growth prospects.The rally follows the release...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02659"],"gpt_icon":1},{"id":"1143595545","title":"BAO PHARMA-B (02659): A Sustainable Growth Model Driven by Its \"Three Pillars\" Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=1143595545","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143595545?lang=en_us&edition=fundamental","pubTime":"2025-12-11 09:24","pubTimestamp":1765416274,"startTime":"0","endTime":"0","summary":"In 2025, Hong Kong's 18A biotech sector has witnessed a long-awaited IPO boom. However, unlike previous cycles, investor sentiment has undergone a profound shift—moving away from blind pursuit of...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"gpt_icon":1},{"id":"1109612777","title":"BAO PHARMA-B (02659) Donates HK$1 Million to Support Tai Po Fire Relief and Reconstruction Efforts in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=1109612777","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109612777?lang=en_us&edition=fundamental","pubTime":"2025-12-10 09:50","pubTimestamp":1765331415,"startTime":"0","endTime":"0","summary":"On November 26, a severe fire broke out in multiple residential buildings at Hong Fuk Court in Tai Po, Hong Kong, resulting in significant casualties and drawing widespread concern from all sectors...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"gpt_icon":1},{"id":"2590075376","title":"Bao Pharmaceuticals Soars 129% in Hong Kong Trading Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2590075376","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590075376?lang=en_us&edition=fundamental","pubTime":"2025-12-10 09:41","pubTimestamp":1765330916,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals' (HKG:2659) shares opened 129% above its initial public offering price in a stellar Hong Kong debut on Wednesday morning.The biotechnology company opened at HK$60.50 per share, compared with the offer price of HK$26.38.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"0f289a0c0f19ee2212a31014a11a9f2a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02659"],"gpt_icon":0},{"id":"1145252546","title":"Stock Track | BAO PHARMA-B Soars 120.81% in Intraday Trading as Stock Debuts at HK$60.5 vs. Offer Price of HK$26.38","url":"https://stock-news.laohu8.com/highlight/detail?id=1145252546","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145252546?lang=en_us&edition=fundamental","pubTime":"2025-12-10 09:32","pubTimestamp":1765330345,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) saw its stock price surge by 120.81% during intraday trading on Wednesday, following its debut on the Hong Kong Stock Exchange.The stock opened at HK$60.5 per share,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"0f289a0c0f19ee2212a31014a11a9f2a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02659"],"gpt_icon":0},{"id":"2590890376","title":"Shares of Shanghai Bao Pharmaceuticals  Set to Open at HK$60.5 Each in Hong Kong Debut VS Offer Price HK$26.38 Apiece","url":"https://stock-news.laohu8.com/highlight/detail?id=2590890376","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590890376?lang=en_us&edition=fundamental","pubTime":"2025-12-10 09:20","pubTimestamp":1765329618,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"0f289a0c0f19ee2212a31014a11a9f2a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nL4N3XG02J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02659"],"gpt_icon":0},{"id":"2590787322","title":"Bao Pharma Nets HK$921.5 Million from Hong Kong IPO Ahead of Trading Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2590787322","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590787322?lang=en_us&edition=fundamental","pubTime":"2025-12-10 06:20","pubTimestamp":1765318813,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals  raised HK$921.5 million in net proceeds from its initial public offering in Hong Kong.The final offer price was set at HK$26.38 per share, according to an after-market filing with the Hong Kong Stock Exchange on Tuesday.The biotechnology company offered 37.9 million H-shares in the global offering.The Hong Kong public offer was 3,526.34 times oversubscribed, with a final allocation of 3.79 million shares, or 10% of the total offering.The international offering was 6.59 times subscribed, with a final allocation of 34.1 million shares, or 90% of the total.Cornerstone investors, including AnkeBio Hong Kong, DC Alpha Fund SPC, and Guotai Junan Investments, were allotted a combined 7.6 million shares, representing 20.06% of the global offering.Shanghai Bao Pharmaceuticals is scheduled to debut on the Hong Kong bourse on Wednesday, Dec. 10.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"0f289a0c0f19ee2212a31014a11a9f2a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02659"],"gpt_icon":1},{"id":"2590477953","title":"BRIEF-Shanghai Bao Pharmaceuticals Announces Final Offer Price HK$26.38 Per H Share Under Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2590477953","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590477953?lang=en_us&edition=fundamental","pubTime":"2025-12-09 23:18","pubTimestamp":1765293486,"startTime":"0","endTime":"0","summary":"BRIEF-Shanghai Bao Pharmaceuticals Announces Final Offer Price HK$26.38 Per H Share Under OfferingDec 9 (Reuters) - Shanghai Bao Pharmaceuticals Co Ltd 2659.HK:FINAL OFFER PRICE HK$26.38 PER H SHARE UNDER OFFERINGFurther company coverage: 2659.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nFWN3XF0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"gpt_icon":0},{"id":"1176360621","title":"Frenzy! Dark Pool Trading Soars Over 113%!","url":"https://stock-news.laohu8.com/highlight/detail?id=1176360621","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176360621?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:10","pubTimestamp":1765285838,"startTime":"0","endTime":"0","summary":"The Hong Kong IPO market is heating up.   Today, BAO PHARMA-B (02659), a new Hong Kong-listed stock, surged over 115% in dark pool trading. Based on a lot size of 100 shares, investors could earn HKD...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","02687"],"gpt_icon":1},{"id":"1194693083","title":"HK Movers | Bao Pharma Jumps 105% in Grey Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1194693083","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194693083?lang=en_us&edition=fundamental","pubTime":"2025-12-09 16:15","pubTimestamp":1765268100,"startTime":"0","endTime":"0","summary":"$Bao Pharma(02659)$ shares jumped 105.3% in in Hong Kong grey market.Founded in 2019, Bao Pharma focuses on four key therapeutic areas, including large-volume subcutaneous drug delivery systems,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"771b03e04e4d4cd469e05db42767a8e9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"gpt_icon":1},{"id":"1165654924","title":"IPO Update | BAO PHARMA-B (02659) Closes Subscription with HK$269.21B Margin Financing, Oversubscribed 2,690.8 Times","url":"https://stock-news.laohu8.com/highlight/detail?id=1165654924","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165654924?lang=en_us&edition=fundamental","pubTime":"2025-12-08 10:47","pubTimestamp":1765162043,"startTime":"0","endTime":"0","summary":"Biotech firm BAO PHARMA-B (02659) concluded its IPO subscription period from December 2 to 5 and is expected to list on December 10. Market data shows that as of last Friday (December 5), the company...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"gpt_icon":1},{"id":"1152935994","title":"Beyond ADC and PD-1 Competition: How Bao Pharma-B Charts a \"Second Growth Curve\" in Biopharma","url":"https://stock-news.laohu8.com/highlight/detail?id=1152935994","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152935994?lang=en_us&edition=fundamental","pubTime":"2025-12-05 13:50","pubTimestamp":1764913847,"startTime":"0","endTime":"0","summary":"As China's biopharmaceutical industry navigates an era of both opportunities and challenges, technological innovation and capital influx drive rapid development while intense homogeneous competition...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PD","BK4231","BK4080","LU1169590202.USD","LU1169589451.USD","BK4023","161726","02659","ADC","399441"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}]}}